Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

  • Michael Anderson, Anish Nadkarni, Leah Cardwell, Hossein Alinia, Steven Feldman
  • Patient Preference and Adherence, July 2017, Dove Medical Press
  • DOI: 10.2147/ppa.s115708

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ppa.s115708

The following have contributed to this page: Michael Anderson

Contributors